m). (D)
qRT-PCR measured tif-ia gene transcription in response to aspirin (10mM for the times specified). Results are presented as the percentage of relative TIF-IA mRNA compared to 0h control. The mean (± s.e.m ) is shown. N=3. (E to H) Aspirin-mediated TIF-IA degradation is independent of MDM2 and dependent on lysosomal and proteasomal pathways. SW480 cells were pre-treated for 2h with DMSO (carrier), the MDM2 inhibitor, Nutlin3 (5µM), MG132 (25µM), Lactacystin (35 M), Quinacrine (25µM), BafilomycinA1 (100nM) or MG132 (10µM) plus quinacrine (25µM). Following aspirin treatment (10mM, 4h or as indicated), TIF-IA levels were monitored by Western blot analysis. (I) SW480 cells were transfected with GFP-TIF-IA then treated with aspirin (10mM) for the times specified. Immunoblot was performed with α GFP antibody. Actin acts as a loading control throughout. P values are compared to the respective control and were derived using a two tailed students T test. 
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